Standardization of a high-performance RT-qPCR for viral load absolute quantification of influenza A pereira2022standardization
Methods/assay standardization study that developed and analytically validated an RT-qPCR absolute quantification assay for influenza A (M gene target) using a plasmid DNA standard. The assay (WHO 2009 M-gene RT-qPCR) was applied to clinical respiratory specimens from a cohort at Hospital de Clínicas, Universidade Federal do Paraná (Curitiba, Brazil). Serial viral-load measurements were obtained for 19 hospitalized SARI patients with two collections (timed by days from symptom onset), including immunocompetent and immunosuppressed participants, to assess viral-load dynamics.
Analytes
respiratory_influenzaA_viral_load
Influenza A viral load by one-step RT-qPCR targeting the influenza A M matrix gene using WHO (2009) primer/probe set on a ViiA 7 Real-Time PCR system. RNA extracted from 200 µL clinical sample (QIAamp Viral RNA Mini Kit). Absolute quantification used a plasmid DNA standard curve (six standards, 10^1 to 10^6 copies/reaction in triplicate). The per-patient serial values here are the absolute quantities tabulated in the paper’s Table 2, in copies/reaction; LOD 6.77 and LOQ 20.52 are reported in the same unit. (The paper additionally converts these to copies/mL and presents Log10 copies/mL in its figures, but the per-patient data used here are the Table 2 copies/reaction values.)
Biomarker: influenza
Specimen:
nasopharyngeal aspirate and nasopharyngeal swab
Units: gc/reaction
Gene target: M
Participants: 19
Negative samples: 3
Positive samples (not quantifiable): 0
Quantifiable samples: 35
Limit of quantification: 20.52
Limit of detection: 6.77